Robinhood Markets (HOOD) has captivated a generation of investors, but its soaring valuation and rich multiples are prompting some on Wall Street to sound the alarm for a potential correction.
In a major consolidation move, Eldorado Gold announces a definitive agreement to acquire Canadian copper-gold developer Foran Mining, positioning the combined entity as a significant near-term producer with a diversified North American and European asset base.
A Wahneta, Florida, resident faces enhanced felony charges including arson and criminal mischief. The Polk County Sheriff's Office states the suspect's illegal immigration status factored into the severity of the allegations, reigniting debates around local enforcement and federal policy.
Despite sitting on over $6 billion in unrealized losses, publicly-listed crypto firm BitMine Immersion Technologies continues its aggressive accumulation of Ethereum, viewing the price slump as a strategic buying opportunity.
The CoinDesk 20 Index, a key benchmark for the digital asset market, fell sharply over the weekend, with every constituent in the red. Ethereum's 13.9% drop was a primary driver of the downturn.
Corn futures extended their recent slide to start the week, pressured by a stronger dollar and ongoing adjustments in trader positioning. Despite robust export commitments, concerns over South American harvest progress and speculative activity are keeping the market on the back foot.
Egypt reopened the Rafah border crossing on Tuesday, allowing the first medical evacuation from Gaza since its latest closure. A critically wounded Palestinian patient was transferred to an Egyptian hospital, amid ongoing hostilities in the Strip.
Palantir Technologies prepares to release its fourth-quarter financial results, with analysts forecasting significant growth despite recent pressure on its stock and broader software sector concerns.
Ryan Dodd, 44, faces multiple felony charges including first-degree murder in the killing of Ashley Stewart, 41, who was found with multiple stab wounds in her Oswego home last week.
SoFi Technologies' record loan originations in Q4 2026 are just the beginning. With a foothold in personal, student, and home loans, the fintech giant is poised to capture a massive share of multi-trillion-dollar markets, driven by refinancing demand and cross-selling to its growing member base.
The Schwab U.S. Dividend Equity ETF (SCHD) offers investors a balanced approach to generating income, targeting financially robust companies with a history of growing dividends. We examine its strategy, performance, and role in a portfolio.
Aptiv reported record fourth-quarter revenue of $5.2 billion, a 3% increase, as the automotive technology leader prepares to spin off its Electrical Distribution Systems business as the independent company Versagen on April 1, 2026.
The all-stock deal creates one of the nation's largest independent oil and gas producers, headquartered in Houston, with combined assets poised to reshape the competitive landscape of the shale sector.
While investors flock to mass-market and electric vehicle stocks, Ferrari's unique strategy of cultivating scarcity and brand prestige has delivered enviable margins and pricing power. With shares well off their highs, analysts debate if now is the time to buy into this iconic automaker for the long haul.
Freedom Capital initiates coverage on Mama's Creations (MAMA) with a Buy rating and a $16 price target, citing the company's expanding national footprint, product innovation, and strong recent earnings as key growth catalysts in the fresh meal sector.
For retirees seeking to increase their monthly income, re-entering the workforce may offer a path to higher Social Security payments—with important considerations.
Congress faces a critical vote to avert a prolonged shutdown, while newly released documents shed light on the Minneapolis shooting involving immigration officers and the Epstein case continues to reverberate.
Apis Capital's flagship fund, which surged 55% in 2025, spotlights clinical-stage biotech Celcuity in its latest investor letter, citing the company's novel platform for matching cancer patients with targeted therapies.
Jefferies has downgraded Amicus Therapeutics to 'Buy' from 'Hold' and trimmed its price target to $14.50, aligning it with BioMarin's pending $4.8 billion acquisition offer. The move reflects analyst skepticism about competing bids emerging for the rare disease biotech firm.
The International Monetary Fund projects average growth in sub-Saharan Africa at 4.6% for the year, edging ahead of Asia's 4.1%, signaling a potential turning point driven by demographics but tempered by significant investment challenges.
